期刊文献+

阴沟肠杆菌染色质ampD基因的研究 被引量:4

Investigation of the genomic ampD and its mutation from Enterobacter cloacae
暂未订购
导出
摘要 目的研究阴沟肠杆菌染色质ampD基因及其高概率突变位点。方法从医院感染患者临床标本中分离阴沟肠杆菌,经头孢西丁初筛试验和头孢西丁三维试验确定是否产AmpCβ-内酰胺酶及其产酶类型,抽提产酶菌株染色质DNA,PCR扩增ampD基因并连接入pMD19-T载体,双链测序后与同种非突变标准菌株的ampD基因序列比对,并得到高概率突变位点。结果大部分产酶阴沟肠杆菌含有ampD基因,其中18株产持续高产型酶菌株的染色质中均扩增出ampD基因;阴沟肠杆菌ampD基因上有62个突变率高于50%的位点。结论产AmpCβ-内酰胺酶的阴沟肠杆菌染色质上均含有ampD基因;阴沟肠杆菌染色质ampD基因的高概率突变位点可能成为致持续高产酶的关键位点。 Objective To explore the genomic ampD and its mutation sites with high probability from Enterobacter cloacae. Methods The strains of Enterobacter cloacae were isolated from the nosocomial infectious patients in our hospital. The ability and the types of AmpC βproducing-lactamases were comfirmed by the improved Cefotaxime three dimensional test. The genomic DNA was extracted,and genomic AmpD was amplified by using PCR, then it was ligated into pMD19-T vector and sequenced. Mutation sites were analyzed by comparing with the AmpD sequence of the standard wild-type strains. Results Most parts of the strains conain genomic ampD. Among them, genomic ampD was amplified in all the clinical isolates pruducing durative high expressed AmpCβ-1actamases. The sequences of ampD were successfully obtained; Enterobacter cloacae contains 62 mutation sites, with the probability being over 50%. Conclusion All the strains of Enterobacter cloacae pruducing durative high expressed AmpC β-lactamases contain genomic ampD; the mutation sites with high probability may be the potential cause of pruducing durative-high-expressed AmpCβ-lactamases.
出处 《国际检验医学杂志》 CAS 2010年第1期11-12,15,共3页 International Journal of Laboratory Medicine
基金 上海市科委重点课题项目(No.054119509)
关键词 肠杆菌 阴沟 Β内酰胺酶类 基因 突变 Enterobacter cloacae beta lactamases Genes Mutation
  • 相关文献

参考文献8

二级参考文献54

  • 1李家泰.临床药理学[M].北京:人民卫生出版社,1997.901-902.
  • 2李家泰.临床病理学[M].北京:人民卫生出版社,1997.575.
  • 3Korfmann G Wiedemann B.Genetic control of β-lactamase production in Enterobacter cloacae[J].Rev Infet Dis,1988,10:793-793.
  • 4[1]Rice LB,Bonomo RA.Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents.In:Lorian V,ed.Antibiotics in laboratory medicine.5th ed.Philadelphia:Williams & Wilkins,2005.441-509.
  • 5[3]National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing;12th informational supplement(M100-S12).Wayne:NCCLS,2002.
  • 6[4]Coudron PE,Moland ES,Thomson KS.Occurrence and detection of AmpC β-lactamases among Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates at a veterans medical center.J Clin Microbiol,2000,38:1791-1796.
  • 7[5]Hidri N,Barnaud G,Decre D,et al.Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the ampC beta-lactamase of a Serratia marcescens clinical isolate.J Antimicrob Chemother,2005,55:496-499.
  • 8[6]Mammeri H,Nazic H,Naas T,et al.ampC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.Antimicrob Agents Chemother,2004,48:4050-4053.
  • 9[7]Mammeri H,Poirel L,Bemer P,et al.Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded ampC beta-lactamase of a Serratia marcescens clinical isolate.Antimicrob Agents Chemother,2004,48:716-720.
  • 10[8]Barnaud G,Benzerara Y,Gravisse J,et al.Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate.Antimicrob Agents Chemother,2004,48:1040-1042.

共引文献83

同被引文献40

  • 1崔颖鹏,黄汉,叶曼曼,陈求刚,陈冬梅,陈菊香,姜傥.164株阴沟肠杆菌的药物敏感性分析[J].中国微生态学杂志,2005,17(2):138-138. 被引量:20
  • 2韩黎,朱士俊,郭燕红,李六亿,胡必杰,武迎宏,袁云娥.中国医务人员执行手卫生的现状调查[J].中华医院感染学杂志,2006,16(2):140-142. 被引量:630
  • 3李轶,蒋燕群,汤瑾,王坚镪,李桂兰.大肠埃希菌、克雷伯菌中质粒AmpC酶的流行分布[J].检验医学,2006,21(5):517-520. 被引量:15
  • 4陈琼娜,李艳波,陈浙华,唐海红,于倩.重症监护病房医院感染病原菌分布及耐药性分析[J].中华医院感染学杂志,2007,17(4):399-400. 被引量:43
  • 5Fuentec MD,Priscila DS,Helia BT,et al.Mutaciones en genes gyrAy gyrBen copas de bacilos Gram negativos aisladas en hostitales chilenos ysu relacion con la Resistencia a Fluoroquino lonas.Rev Med Chile,2007,135(9):1103-1110.
  • 6Black JA,Moland ES,Thomson KS.Ampc disk test for detection of plasmid-mediated Ampc-β lactamases in Enterobacteriaceae lacking chromosomal Ampc-β lactamases.Clin Microboiol 2005,43(7):3110-3113.
  • 7Tsai TY,Chang SC,Hsueh PR,et al.In vitro activity of isepamicin and other aminoglycosides against clinical siolates of Gram-negative bacteria causing nosocomial bloodstream infections.J Microbil Immunol infect,2007,40(6):481-486.
  • 8Gupta V.An update on newer β-lateamases.Indin J Med Res,2007,126(11):417-427.
  • 9Walsh TR,MarK AT,Laurent P,et al.Metallo-beta-lactamases:the quiet before the storm? Clin Microbiol Rev,2005,18:306-325.
  • 10Paterson DL,Bonomo RA.Extended-spectrum beta-lactamaese a clinical update.Clin Microbiol Rev,2005,18:657-686.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部